tiprankstipranks
PTC Therapeutics sees FY24 revenue ~$814M, consensus $795.38M
PremiumThe FlyPTC Therapeutics sees FY24 revenue ~$814M, consensus $795.38M
5d ago
PTC Therapeutics price target lowered to $58 from $63 at RBC Capital
Premium
The Fly
PTC Therapeutics price target lowered to $58 from $63 at RBC Capital
11d ago
PTC Therapeutics submits NDA for vatiquinone in Friedreich ataxia
Premium
The Fly
PTC Therapeutics submits NDA for vatiquinone in Friedreich ataxia
30d ago
PTC Therapeutics price target raised to $71 from $47 at UBS
PremiumThe FlyPTC Therapeutics price target raised to $71 from $47 at UBS
2M ago
PTC Therapeutics price target raised to $70 from $52 at Baird
Premium
The Fly
PTC Therapeutics price target raised to $70 from $52 at Baird
2M ago
PTC Therapeutics price target raised to $41 from $31 at BofA
Premium
The Fly
PTC Therapeutics price target raised to $41 from $31 at BofA
2M ago
PTC Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
PremiumThe FlyPTC Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
2M ago
PTC Therapeutics Partners with Novartis for Huntington’s Program
Premium
Company Announcements
PTC Therapeutics Partners with Novartis for Huntington’s Program
2M ago
PTC Therapeutics enters global license, collaboration agreement with Novartis
Premium
The Fly
PTC Therapeutics enters global license, collaboration agreement with Novartis
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100